Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edwin Itenberg

Colon & Rectal Surgery Southfield, MI Doctor of Osteopathy

NPI 1255508487 CMS profile 328753

16001 W 9 Mile Rd, Fisher Building 3Rd Floor, Southfield, MI 48075

Open in the dashboard

General payments

$11,283

27 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Edwin Itenberg of Southfield, MI is reported in the CMS Open Payments database as having received $11,283 across 27 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $153 1
2024 General $51 1
2023 General $10,053 16
2019 General $1,026 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edwin Itenberg
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Edwin Itenberg were reported at $153. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Edwin Itenberg Colon & Rectal Surgery median Middle half National median
2019 $1,026 $443 $125–$2,179 $163
2020 $0 $167 $53–$931 $114
2021 $0 $207 $72–$1,272 $132
2022 $0 $341 $111–$1,587 $149
2023 $10,053 $322 $115–$1,420 $160
2024 $51 $328 $112–$1,354 $164
2025 $153 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $10,073 17 payments
  2. Olympus Corporation of the Americas $909 7 payments
  3. Medtronic, Inc. $153 1 payment
  4. Abbott Laboratories $97 1 payment
  5. CONMED Corporation $51 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $8,300 6 payments
  2. Travel and Lodging $2,320 12 payments
  3. Food and Beverage $663 9 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $9,913 15 payments
  2. EVIS EXERA $909 7 payments
  3. Olympus Capital Accessories $909 7 payments
  4. Olympus Surgical Accessories $891 6 payments
  5. Olympus Laparoscopic Accessories $891 6 payments
  6. DA VINCI SP $160 2 payments
  7. INTERSTIM $153 1 payment
  8. PERCLOSE PROGLIDE $97 1 payment
  9. AIRSEAL $51 1 payment
  10. Olympus Laparoscopes $18 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

242

Median for Colorectal Surgery (Proctology): 106

Drug cost

$3,009

Median for Colorectal Surgery (Proctology): $1,614

Branded share of claims

53.7%

Median for Colorectal Surgery (Proctology): 35.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 62 $1,157
Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl Brand 38 $793
Loperamide Loperamide Hcl Brand 17 $345
Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine Brand 13 $301
Neomycin Sulfate Generic 48 $286
Metronidazole Generic 47 $99
Oxycodone Hcl Generic 17 $29

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,507 Part D prescribers listed as Colorectal Surgery (Proctology); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$40,269

Medicare's payments for the services billed

Medicare patients

120

Average age 72

Services billed

237

67 women, 53 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 42%
Ischemic heart disease 40%
Cancer 39%
Diabetes 30%
Chronic kidney disease 30%
Depression 27%
COPD 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

27 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record